About Emmes
Emmes is a company based in United States founded in 1977 was acquired by New Mountain Capital in June 2022. The company has 126 employees as of April 08, 2024. Emmes has completed 7 acquisitions, including Casimir, Clinical Edge and Essex Management. Emmes offers products and services including Biostatistics, Clinical Data Management, and Clinical Trial Management. Emmes operates in a competitive market with competitors including Celgene, Syneos Health, Medelis WCCT Global, Parexel and PRA Health Sciences, among others.
- Headquarter United States
- Employees 126 as on 08 Apr, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Emmes Services Private Limited
- Date of Incorporation 24 Apr, 2006
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$3.15 M (USD)95.61as on Mar 31, 2022
-
Net Profit
$666.29 K (USD)536.12as on Mar 31, 2022
-
EBITDA
$1.11 M (USD)430.21as on Mar 31, 2022
-
Latest Funding Round
$224.15 K (USD), Grant
Mar 01, 2022
-
Investors
HHS
& 3 more
-
Employee Count
126
as on Apr 08, 2024
-
Investments & Acquisitions
Casimir
& 6 more
-
Acquired by
New Mountain Capital
(Jun 21, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Emmes
Emmes offers a comprehensive portfolio of products and services, including Biostatistics, Clinical Data Management, and Clinical Trial Management.
Statistical services for managing clinical trial data
Services for organizing and securing clinical research data
End-to-end management of clinical trials and studies
People of Emmes
Unlock access to complete
Funding Insights of Emmes
Investors in Emmes
Emmes has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, European Union and Behrman Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm investing in buyouts of growth companies
|
Locked | Locked | Locked | |
|
New Mountain Capital manages investments in private equity, credit, and net lease strategies.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Emmes
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Emmes
Emmes has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include Casimir, Clinical Edge and Essex Management.
Investment portfolio details for Emmes
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Clinical supply chain services are provided by CRO for trials.
|
Locked | Locked | 2016 | Locked | |
|
Rare diseases and orphan drugs development services are specialized in.
|
Locked | Locked | 2012 | Locked | |
|
Vaccine clinical trials are managed and monitored by VaxTrials.
|
Locked | Locked | 2012 | Locked |
Complete acquisition details for Emmes
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Emmes
Detailed financials for Emmes
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Emmes Comparisons
Peer comparison for Emmes
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Emmes
Emmes operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Syneos Health, Medelis WCCT Global, Parexel and PRA Health Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for cancer and inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
CRO clinical development services are provided by Syneos Health.
|
|
| Locked | Locked | Locked |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| Locked | Locked | Locked |
Full-service clinical research organization services are provided globally by Parexel.
|
|
| Locked | Locked | Locked |
Global full-service CRO services are delivered in over 80 countries.
|
Detailed competitors of Emmes
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Emmes
Complete news archive for Emmes
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Emmes
Emmes was founded in 1977 and raised its 1st funding round 30 years after it was founded.
Emmes is headquartered in United States.
As of Apr 08, 2024, the latest employee count at Emmes is 126.
Annual revenue of Emmes is $3.15M as on Mar 31, 2022.
Emmes was founded in 1977 and is headquartered in the United States. Operations focus on the healthcare sector, where clinical research services are delivered on an outsourced basis. Support is extended to pharmaceutical, biotechnology, and medical device industries through trial management, data analysis, and regulatory compliance. Activities are conducted primarily within North America, with services tailored to various therapeutic areas.
Emmes's top competitors include Syneos Health, ClinChoice and Veristat.
Emmes offers Biostatistics, Clinical Data Management, and Clinical Trial Management.
Emmes has made 7 acquisitions, including Casimir, Clinical Edge, and Essex Management.
Emmes has 4 investors. Key investors include HHS, European Union, Behrman Capital, and New Mountain Capital.